MedPath

江西和明制药有限公司

Ownership
-
Established
2014-12-04
Employees
-
Market Cap
-
Website
http://www.jxheming.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

37

NMPA:37

Drug Approvals

Rifandine Capsules

Product Name
利福定胶囊
Approval Number
国药准字H36022137
Approval Date
Jul 16, 2022
NMPA

板蓝根糖浆

Approval Number
国药准字Z20055293
Approval Date
Jun 7, 2022
NMPA

Compound Balloonflower and Ephedrine Syrup

Product Name
复方桔梗麻黄碱糖浆
Approval Number
国药准字H36022396
Approval Date
Dec 23, 2021
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H36021391
Approval Date
Sep 23, 2021
NMPA

Pediatric Sulfamethoxazole,Sulfadiazine and Trimethoprim Granules

Product Name
小儿双磺甲氧苄啶颗粒
Approval Number
国药准字H36022117
Approval Date
Sep 23, 2021
NMPA

生三七散

Approval Number
国药准字Z36021608
Approval Date
Sep 23, 2021
NMPA

Lincomycin Hydrochloride Capsules

Product Name
盐酸林可霉素胶囊
Approval Number
国药准字H36020383
Approval Date
Sep 23, 2021
NMPA

复方胆通胶囊

Approval Number
国药准字Z36020480
Approval Date
Sep 23, 2021
NMPA

羚翘解毒片

Approval Number
国药准字Z36021246
Approval Date
Sep 23, 2021
NMPA

Indometacin Capsules

Product Name
吲哚美辛胶囊
Approval Number
国药准字H36020382
Approval Date
Sep 22, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.